WeChat· 君实医学·· 4 hours agoPickScore68
Toripalimab Consolidation in Limited-Stage Small Cell Lung Cancer: GASTO-1052A Full Results Published in JITC
In brief
The full results of the GASTO-1052A study were published in the Journal for ImmunoTherapy of Cancer (JITC, IF=11.7). Toripalimab consolidation therapy significantly prolonged progression-free survival versus observation in limited-stage small cell lung cancer (LS-SCLC), with a PFS hazard ratio of 0.55.
Why it matters
The paper provides PFS and OS hazard ratios with confidence intervals and manageable safety, enabling direct comparison with similar consolidation regimens in LS-SCLC.
Source: WeChat · mp.weixin.qq.com